Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity.
Journal Information
Full Title: ChemMedChem
Abbreviation: ChemMedChem
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest The authors declare no conflict of interest."
Funding Disclosure
Evidence found in paper:
"We thank Prof. A.C. Filippou, R. Pacher, M. Schneider, C. Vielmuth, L.P. Vu (University of Bonn, Bonn, Germany), R. Schlichting (Helmholtz Centre for Environmental Research‐UFZ, Leipzig, Germany), and M. Frelih (University of Ljubljana, Ljubljana, Slovenia), for their support and technical assistance. This project was funded by the Volkswagen Foundation (project 9 A894, COOP). Open Access funding enabled and organized by Projekt DEAL."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025